Uveal melanoma: epidemiology, etiology, and treatment of primary disease

References

• McLaughlinCCWuXCJemalAMartinHJRocheLMChenVWIncidence of noncutaneous melanomas in the U.SCancer200510351000100715651058
   PubMed Web of Science ®Google Scholar
• SinghADTophamAIncidence of uveal melanoma in the United States: 1973–1997Ophthalmology2003110595696112750097
   PubMed Web of Science ®Google Scholar
• DamatoBProgress in the management of patients with uveal melanoma: the 2012 Ashton LectureEye (Lond)20122691157117222744385
   PubMed Web of Science ®Google Scholar
• DamatoEMDamatoBEDetection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patientsOphthalmology201211981582158922503229
   PubMed Web of Science ®Google Scholar
• AndreoliMTMielerWFLeidermanYIEpidemiological trends in uveal melanomaBr J Ophthalmol201599111550155325904122
   PubMed Web of Science ®Google Scholar
• SinghADTurellMETophamAKUveal melanoma: trends in incidence, treatment, and survivalOphthalmology201111891881188521704381
   PubMed Web of Science ®Google Scholar
• HuDNYuGPMcCormickSASchneiderSFingerPTPopulation-based incidence of uveal melanoma in various races and ethnic groupsAm J Ophthalmol2005140461261716226513
   PubMed Web of Science ®Google Scholar
• VirgiliGGattaGCiccolalloLIncidence of uveal melanoma in EuropeOphthalmology2007114122309231517498805
   PubMed Web of Science ®Google Scholar
• ParkSJOhCMKimBWWooSJChoHParkKHNationwide incidence of ocular melanoma in South Korea by using the National Cancer Registry Database (1999–2011)Invest Ophthalmol Vis Sci20155684719472426207308
   PubMed Web of Science ®Google Scholar
• ShieldsCLKalikiSLiveseyMAssociation of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyesJAMA Ophthalmol20131318993100323681424
   PubMed Web of Science ®Google Scholar
• WeisEShahCPLajousMShieldsJAShieldsCLThe association of cutaneous and iris nevi with uveal melanoma: a meta-analysisOphthalmology20091163536543.e219167086
   PubMed Web of Science ®Google Scholar
• HarbourJWOnkenMDRobersonEDFrequent mutation of BAP1 in metastasizing uveal melanomasScience201033060091410141321051595
   PubMed Web of Science ®Google Scholar
• GallagherRPElwoodJMRootmanJRisk factors for ocular melanoma: Western Canada Melanoma StudyJ Natl Cancer Inst19857447757783857374
   PubMedGoogle Scholar
• LainsIBartoschCMondimVSecond primary neoplasms in patients with uveal melanoma: a SEER database analysisAm J Ophthalmol2016165546426940164
   PubMed Web of Science ®Google Scholar
• TuckerMAShieldsJAHartgePAugsburgerJHooverRNFraumeniJFJrSunlight exposure as risk factor for intraocular malignant melanomaN Engl J Med1985313137897924033707
   PubMed Web of Science ®Google Scholar
• ShahCPWeisELajousMShieldsJAShieldsCLIntermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysisOphthalmology200511291599160716051363
   PubMed Web of Science ®Google Scholar
• de LangeMJRazzaqLVersluisMDistribution of GNAQ and GNA11 mutation signatures in uveal melanoma points to a light dependent mutation mechanismPLoS One2015109e013800226368812
   PubMed Web of Science ®Google Scholar
• ShieldsCLFurutaMBermanELChoroidal nevus transformation into melanoma: analysis of 2514 consecutive casesArch Ophthalmol2009127898198719667334
   PubMedGoogle Scholar
• ShieldsJASanbornGEAugsburgerJJThe differential diagnosis of malignant melanoma of the iris: a clinical study of 200 patientsOphthalmology19839067167206888862
   PubMed Web of Science ®Google Scholar
• ShieldsJAAugsburgerJJBrownGCStephensRFThe differential diagnosis of posterior uveal melanomaOphthalmology19808765185227413140
   PubMed Web of Science ®Google Scholar
• No authors listedAccuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study: COMS report no. 1Arch Ophthalmol19901089126812732205183
   PubMedGoogle Scholar
• ShieldsJAShieldsCLEhyaHEagleRCJrDe PotterPFine-needle aspiration biopsy of suspected intraocular tumorsInt Ophthalmol Clin19933337782
   Google Scholar
• CharDHMillerTAccuracy of presumed uveal melanoma diagnosis before alternative therapyBr J Ophthalmol19957976926967662638
   PubMed Web of Science ®Google Scholar
• McCannelTAFine-needle aspiration biopsy in the management of choroidal melanomaCurr Opin Ophthalmol201324326226623455150
   PubMed Web of Science ®Google Scholar
• RietschelPPanageasKSHanlonCPatelAAbramsonDHChapmanPBVariates of survival in metastatic uveal melanomaJ Clin Oncol200523318076808016258106
   PubMed Web of Science ®Google Scholar
• Diener-WestMReynoldsSMAgugliaroDJDevelopment of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group report no. 26Arch Ophthalmol2005123121639164316344433
   PubMed Web of Science ®Google Scholar
• KujalaEMakitieTKivelaTVery long-term prognosis of patients with malignant uveal melanomaInvest Ophthalmol Vis Sci200344114651465914578381
   PubMed Web of Science ®Google Scholar
• KukDShoushtariANBarkerCAPrognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasisOncologist201621784885427286787
   PubMed Web of Science ®Google Scholar
• ShieldsCLKalikiSFurutaMFulcoEAlarconCShieldsJAAmerican Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7,731 patientsOphthalmology2013120102066207123664467
   PubMed Web of Science ®Google Scholar
• ShieldsCLKalikiSFurutaMFulcoEAlarconCShieldsJAAmerican Joint Committee on Cancer classification of uveal melanoma (anatomic stage) predicts prognosis in 7,731 patients: the 2013 Zimmerman LectureOphthalmology201512261180118625813452
   PubMed Web of Science ®Google Scholar
• VersluisMde LangeMJvan PeltSIDigital PCR validates 8q dosage as prognostic tool in uveal melanomaPLoS One2015103e011637125764247
   PubMed Web of Science ®Google Scholar
• EwensKGKanetskyPARichards-YutzJGenomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcomeInvest Ophthalmol Vis Sci20135485721572923821189
   PubMed Web of Science ®Google Scholar
• OnkenMDWorleyLACharDHCollaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanomaOphthalmology201211981596160322521086
   PubMed Web of Science ®Google Scholar
• FieldMGDecaturCLKurtenbachSPRAME as an independent biomarker for metastasis in uveal melanomaClin Cancer Res20162251234124226933176
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas NetworkGenomic classification of cutaneous melanomaCell201516171681169626091043
   PubMed Web of Science ®Google Scholar
• KalinecGNazaraliAJHermouetSXuNGutkindJSMutated α subunit of the Gq protein induces malignant transformation in NIH 3T3 cellsMol Cell Biol19921210468746931328859
   PubMed Web of Science ®Google Scholar
• Van RaamsdonkCDBezrookoveVGreenGFrequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature2009457722959960219078957
   PubMed Web of Science ®Google Scholar
• Van RaamsdonkCDGriewankKGCrosbyMBMutations in GNA11 in uveal melanomaN Engl J Med2010363232191219921083380
   PubMed Web of Science ®Google Scholar
• Piperno-NeumannSKapiteijnELarkinJMLandscape of genetic alterations in patients with metastatic uveal melanomaJ Clin Oncol2014325 Suppl9043
   Web of Science ®Google Scholar
• GriewankKGvan de NesJSchillingBGenetic and clinicopathologic analysis of metastatic uveal melanomaMod Pathol201427217518323887304
   PubMed Web of Science ®Google Scholar
• XuXWeiWBLiBGaoFZhangZJonasJBOncogenic GNAQ and GNA11 mutations in uveal melanoma in ChinesePLoS One2014910e10969925280020
   PubMed Web of Science ®Google Scholar
• JohanssonPAoudeLGWadtKDeep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4Oncotarget2016744624463126683228
   PubMedGoogle Scholar
• MooreARCeraudoESherJJRecurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanomaNat Genet201648667568027089179
   PubMed Web of Science ®Google Scholar
• ShoushtariANCarvajalRDGNAQ and GNA11 mutations in uveal melanomaMelanoma Res201424652553425304237
   PubMed Web of Science ®Google Scholar
• LeeCHParkDWuDRheeSGSimonMIMembers of the Gq α subunit gene family activate phospholipase C β isozymesJ Biol Chem19922672316044160471322889
   PubMed Web of Science ®Google Scholar
• WuDQLeeCHRheeSGSimonMIActivation of phospholipase C by the α subunits of the Gq and G11 proteins in transfected Cos-7 cellsJ Biol Chem19922673181118171309799
   PubMed Web of Science ®Google Scholar
• RozengurtEMitogenic signaling pathways induced by G protein-coupled receptorsJ Cell Physiol2007213358960217786953
   PubMed Web of Science ®Google Scholar
• CobbMHGoldsmithEJHow MAP kinases are regulatedJ Biol Chem19952702514843148467797459
   PubMed Web of Science ®Google Scholar
• PopuloHSoaresPRochaASSilvaPLopesJMEvaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanomaMelanoma Res201020210711720173664
   PubMed Web of Science ®Google Scholar
• BabchiaNCalipelAMouriauxFFaussatAMMascarelliFThe PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERKInvest Ophthalmol Vis Sci201051142142919661225
   PubMed Web of Science ®Google Scholar
• KhaliliJSYuXWangJCombination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent mannerClin Cancer Res201218164345435522733540
   PubMed Web of Science ®Google Scholar
• HoALMusiEAmbrosiniGImpact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotypePLoS One201277e4043922808163
   PubMed Web of Science ®Google Scholar
• OverholtzerMZhangJSmolenGATransforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconProc Natl Acad Sci U S A200610333124051241016894141
   PubMed Web of Science ®Google Scholar
• ZhaoBYeXYuJTEAD mediates YAP-dependent gene induction and growth controlGenes Dev200822141962197118579750
   PubMed Web of Science ®Google Scholar
• HaoYChunACheungKRashidiBYangXTumor suppressor LATS1 is a negative regulator of oncogene YAPJ Biol Chem200828395496550918158288
   PubMed Web of Science ®Google Scholar
• FengXDegeseMSIglesias-BartolomeRHippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated Rho GTPase signaling circuitryCancer Cell201425683184524882515
   PubMed Web of Science ®Google Scholar
• YavuzyigitogluSKoopmansAEVerdijkRMUveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastasesOphthalmology201612351118112826923342
   PubMed Web of Science ®Google Scholar
• HarbourJWRobersonEDAnbunathanHOnkenMDWorleyLABowcockAMRecurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanomaNat Genet201345213313523313955
   PubMed Web of Science ®Google Scholar
• MartinMMasshöferLTemmingPExome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3Nat Genet201345893393623793026
   PubMed Web of Science ®Google Scholar
• MaatWvan der VeldenPAOut-LuitingCEpigenetic inactivation of RASSF1a in uveal melanomaInvest Ophthalmol Vis Sci200748248649017251440
   PubMed Web of Science ®Google Scholar
• MerhaviECohenYAvrahamBCPromoter methylation status of multiple genes in uveal melanomaInvest Ophthalmol Vis Sci200748104403440617898258
   PubMed Web of Science ®Google Scholar
• RajaiiFAsnaghiLEnkeRMerbsSLHandaJTEberhartCGThe demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanomaInvest Ophthalmol Vis Sci201455106178618625146981
   PubMed Web of Science ®Google Scholar
• VenzaMVisalliMCatalanoTDNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanomaOncol Rep20163542451246026883095
   PubMed Web of Science ®Google Scholar
• EldhMBaggeROLasserCMicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanomaBMC Cancer20141496225510783
   PubMed Web of Science ®Google Scholar
• ChenXHeDDa DongXMicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma miR-124a is a tumor suppressor in uveal melanomaInvest Ophthalmol Vis Sci20135432248225623404119
   PubMed Web of Science ®Google Scholar
• ChenXWangJShenHEpigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanomaInvest Ophthalmol Vis Sci20115231193119921051724
   PubMed Web of Science ®Google Scholar
• DongFLouDMicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targetsMol Vis20121853754622419847
   PubMed Web of Science ®Google Scholar
• WenXLuLHeZFanXOrchestrating epigenetic roles targeting ocular tumorsOnco Targets Ther201691001100927013893
   PubMed Web of Science ®Google Scholar
• Collaborative Ocular Melanoma Study GroupThe COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28Arch Ophthalmol2006124121684169317159027
   PubMedGoogle Scholar
• TarmannLWackernagelWAvianARuthenium-106 plaque brachytherapy for uveal melanomaBr J Ophthalmol201599121644164925979763
   PubMed Web of Science ®Google Scholar
• American Brachytherapy Society – Ophthalmic Oncology Task ForceThe American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastomaBrachytherapy201413111424373763
   PubMed Web of Science ®Google Scholar
• PuusaariIDamatoBKiveläTTransscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour heightGraefes Arch Clin Exp Ophthalmol2007245452253317111148
   PubMed Web of Science ®Google Scholar
• FingerPTChinKJDuvallGPalladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patientsOphthalmology20091164790796.e119243829
   PubMed Web of Science ®Google Scholar
• CaminalJPadrón-PérezNAriasLTransscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanomaEye (Lond)201630683384227034202
   PubMed Web of Science ®Google Scholar
• BechrakisNEBornfeldNZöllerIFoersterMHIodine 125 plaque brachytherapy versus transscleral tumor resection in the treatment of large uveal melanomasOphthalmology2002109101855186112359606
   PubMed Web of Science ®Google Scholar
• ShahSUShieldsCLBianciottoCGIntravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanomaOphthalmology2014121126927524139123
   PubMed Web of Science ®Google Scholar
• MishraKKQuiveyJMDaftariIKLong-term results of the UCSF-LBNL randomized trial: charged particle with helium ion versus iodine-125 plaque therapy for choroidal and ciliary body melanomaInt J Radiat Oncol Biol Phys201592237638325841624
   PubMed Web of Science ®Google Scholar
• BensoussanEThariatJMaschiCOutcomes after proton beam therapy for large choroidal melanomas in 492 patientsAm J Ophthalmol2016165788726940166
   PubMed Web of Science ®Google Scholar
• SeibelICordiniDRehakMLocal recurrence after primary proton beam therapy in uveal melanoma: risk factors, retreatment approaches, and outcomeAm J Ophthalmol2015160462863626133249
   PubMed Web of Science ®Google Scholar
• HawkinsBSThe Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24Am J Ophthalmol2004138693695115629284
   PubMed Web of Science ®Google Scholar
• MeliaMMoyCSReynoldsSMQuality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS report no. 3Arch Ophthalmol2006124222623816476893
   PubMed Web of Science ®Google Scholar
• WillerdingGDCordiniDMoserLKrauseLFoersterMHBechrakisNENeoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 casesBr J Ophthalmol2016100446346726224096
   PubMed Web of Science ®Google Scholar
• KivelaTPuusaariIDamatoBTransscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control studyOphthalmology2003110112235224414597535
   PubMed Web of Science ®Google Scholar
• BechrakisNEPetousisVWillerdingGTen-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rateBr J Ophthalmol201094446046619965818
   PubMed Web of Science ®Google Scholar
• BadiyanSNRaoRCApicelliAJOutcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapyInt J Radiat Oncol Biol Phys201488480180524462385
   PubMed Web of Science ®Google Scholar
• SaakianSVVal’skiiVVSemenovaEAAmirianAGTranspupillary thermotherapy in the treatment of recurrent and residual choroidal melanomas: preliminary resultsVestn Oftalmol200912561115 Russian
   Google Scholar
• HarbourJWMeredithTAThompsonPAGordonMETranspupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomasOphthalmology2003110112207221514597531
   PubMed Web of Science ®Google Scholar
• TurcotteSBergeronDRousseauAPMouriauxFPrimary transpupillary thermotherapy for choroidal indeterminate melanocytic lesionsCan J Ophthalmol201449546446725284104
   PubMed Web of Science ®Google Scholar
• MashayekhiAShieldsCLRishiPPrimary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor controlOphthalmology2015122360060925439431
   PubMed Web of Science ®Google Scholar
• YarovoyAAMagaramovDABulgakovaESThe comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy aloneBrachytherapy201211322422922104351
   PubMed Web of Science ®Google Scholar
• WalkerTMVan GinkelPRGeeRLExpression of angiogenic factors Cyr61 and tissue factor in uveal melanomaArch Ophthalmol2002120121719172512470148
   PubMedGoogle Scholar
• KinesRCCerioRJRobertsJNHuman papillomavirus capsids preferentially bind and infect tumor cellsInt J Cancer2016138490191126317490
   PubMed Web of Science ®Google Scholar
• Business WireFDA grants orphan drug designation to Aura Biosciences’ novel treatment for uveal melanoma2015 Available from: http://www.businesswire.com/news/home/20150521005822/en/FDA-Grants-Orphan-Drug-Designation-Aura-Biosciences%E2%80%99Accessed November 26, 2016
   Google Scholar
• TorresVTriozziPEngCCirculating tumor cells in uveal melanomaFuture Oncol20117110110921174541
   PubMed Web of Science ®Google Scholar
• DesjardinsLDorvalTLevyCEtude randomisée de chimiothérapie adjuvante par le deticène dans le mélanome choroïdien [Randomized study of adjuvant chemotherapy with dacarbazine in choroidal melanoma]Ophtalmologie1998123168173 French
   Google Scholar
• LaneAMEganKMHarmonDHolbrookAMunzenriderJEGragoudasESAdjuvant interferon therapy for patients with uveal melanoma at high risk of metastasisOphthalmology2009116112206221219744725
   PubMed Web of Science ®Google Scholar
• RichtigELangmannGSchlemmerGSafety and efficacy of interferon alfaα-2b in the adjuvant treatment of uveal melanomaOphthalmologe20061036506511 German16763868
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkNCCN Guidelines: Melanoma Version 3.2016Fort Washington (PA)NCCN2016
   Google Scholar
• LeyvrazSSpataroVBauerJTreatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapyJ Clin Oncol1997157258925959215829
   PubMed Web of Science ®Google Scholar
• VoelterVSchalenbourgAPampallonaSAdjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patientsMelanoma Res200818322022418477897
   PubMed Web of Science ®Google Scholar
• LeyvrazSPiperno-NeumannSSuciuSHepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trialAnn Oncol201425374274624510314
   PubMed Web of Science ®Google Scholar
• EderJPVande WoudeGFBoernerSALoRussoPMNovel therapeutic inhibitors of the c-Met signaling pathway in cancerClin Cancer Res20091572207221419318488
   PubMed Web of Science ®Google Scholar
• LiangJWuYLChenBJZhangWTanakaYSugiyamaHThe c-Kit receptor-mediated signal transduction and tumor-related diseasesInt J Biol Sci20139543544323678293
   PubMed Web of Science ®Google Scholar
• SatoTHanFYamamotoAThe biology and management of uveal melanomaCurr Oncol Rep200810543143818706273
   PubMed Web of Science ®Google Scholar
• SurrigaORajasekharVKAmbrosiniGDoganYHuangRSchwartzGKCrizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma modelMol Cancer Ther201312122817282624140933
   PubMed Web of Science ®Google Scholar
• ValsecchiMEOrloffMMChervonevaIPotential survival benefit of adjuvant sunitinib in high risk uveal melanomaJ Clin Oncol201533Supple20046
   Google Scholar
• LandrevilleSAgapovaOAMatatallKAHistone deacetylase inhibitors induce growth arrest and differentiation in uveal melanomaClin Cancer Res201218240841622038994
   PubMed Web of Science ®Google Scholar
• KaisermanIAmerRPe’erJLiver function tests in metastatic uveal melanomaAm J Ophthalmol2004137223624314962411
   PubMed Web of Science ®Google Scholar
• KoutsandreaCMoschosMMDimissianosMGeorgopoulosGLadasIApostolopoulosMMetastasis rates and sites after treatment for choroidal melanoma by proton beam irradiation or by enucleationClin Ophthalmol20082498999519668458
   PubMedGoogle Scholar
• FrancisJHPatelSPGombosDSCarvajalRDSurveillance options for patients with uveal melanoma following definitive managementAm Soc Clin Oncol Educ Book201338238723714555
   PubMedGoogle Scholar
• FranckenABFulhamMJMillwardMJThompsonJFDetection of metastatic disease in patients with uveal melanoma using positron emission tomographyEur J Surg Oncol200632778078416765562
   PubMed Web of Science ®Google Scholar
• ChattopadhyayCKimDWGombosDSUveal melanoma: from diagnosis to treatment and the science in betweenCancer2016122152299231226991400
   PubMed Web of Science ®Google Scholar
• Piperno-NeumannSServoisVMarianiPProspective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patientsJ Fr Ophtalmol201538652653425978872
   PubMed Web of Science ®Google Scholar
• MarshallERomaniukCGhanehPMRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patientsBr J Ophthalmol201397215916323159448
   PubMed Web of Science ®Google Scholar
• WenJCSaiVStraatsmaBRMcCannelTARadiation-related cancer risk associated with surveillance imaging for metastasis from choroidal melanomaJAMA Ophthalmol20131311566123307209
   PubMed Web of Science ®Google Scholar
• CarvajalRDSchwartzGKTezelTMarrBFrancisJHNathanPDMetastatic disease from uveal melanoma: treatment options and future prospectsBr J Ophthalmol Epub2016829
   Web of Science ®Google Scholar
• GuanXWangHMaFQianHYiZXuBThe efficacy and safety of programmed cell death 1 and programmed cell death 1 ligand inhibitors for advanced melanoma: a meta-analysis of clinical trials following the PRISMA guidelinesMedicine (Baltimore)20169511e313426986169
   PubMed Web of Science ®Google Scholar
• BossiGBuissonSOatesJJakobsenBKHassanNJImmTAC- redirected tumour cell killing induces and potentiates antigen cross- presentation by dendritic cellsCancer Immunol Immunother201463543744824531387
   PubMed Web of Science ®Google Scholar
• Marquez-RodasICerezuelaPSoriaAImmune checkpoint inhibitors: therapeutic advances in melanomaAnn Transl Med201531826726605313
   PubMed Web of Science ®Google Scholar
• MiddletonMRStevenNMEvansTJSafety, pharmacokinetics and efficacy of IMCgp100, a first-in-class soluble TCR-antiCD3 bispecific T cell redirector with solid tumour activity: results from the FIH study in melanomaJ Clin Oncol201634Suppl3016
   Web of Science ®Google Scholar